| 02.12.2022 22:26:25 | |
|---|---|
| Cena | |
| 169,84 EUR | |
| Změna | 0,00% (0,00) |
Základní údaje
| ISIN | US4781601046 |
| Symbol | JNJ |
| Burza | Tradegate |
| Měna | EUR |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 444.265 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | 169,50 EUR (88) |
| Prodej (částka) | 170,02 EUR (88) |
| Otevírací cena | 169,76 EUR |
| Max | 170,66 EUR |
| Min | 168,72 EUR |
| Závěrečná cena (předchozí den) | 169,84 EUR |
| Cena vážená obchodovaným objemem | 169,64646 EUR |
| Objem (kusy) | 4.706 |
| Obchodovaný objem | 798.356,26 |
| Počet obchodů | 142 |
| Poslední zobchodovaný počet | - |
Futures a opce
| Související Futures | 15 |
| Související Opce | - |
PDF ke stažení
| Report společnosti: JOHNSON & JOHNSON |  |
Stupnice: ABS REL
Nástroj/produkt
Přidat benchmark:
Minulá výkonnost nezaručuje výkonnost budoucí.Zdroj: FactSet
Aktuální analýzy a prognózy
| Datum | Nadpis | Stáhnout | |
| 28.11.2022 |
|
Global Equity Ratings |
|
| 18.11.2022 |
|
Global Equity Ratings |
|
| 31.10.2022 |
|
Global Equity Ratings |
|
| 05.10.2022 |
|
Global Equity Ratings |
|
| 26.09.2022 |
|
Global Equity Ratings |
|
Všechny burzy pro JOHNSON & JOHNSON
| Burza | Datum | Čas | Cena | Obchodovaný objem (mil.) | Počet obchodů |
| Xetra | 02.12.2022 | 17:35 | 169,22 EUR | 0,31 | 107 |
| Vienna Stock Exchange | 02.12.2022 | 17:32 | 169,14 EUR | 0,00 | 3 |
| Tradegate | 02.12.2022 | 22:26 | 169,84 EUR | 0,80 | 142 |
| Stuttgart | 02.12.2022 | 21:59 | 169,74 EUR | 0,08 | 9 |
| SIX Swiss Exchange | 30.03.2020 | 17:35 | 150,00 USD | 0,00 | 1 |
| SIX Swiss Exchange | 23.11.2022 | 17:36 | 170,00 CHF | 0,00 | 1 |
| NYSE | 02.12.2022 | 22:00 | 178,88 USD | 1.037,18 | 77.982 |
| Munich | 02.12.2022 | 08:01 | 169,74 EUR | 0,00 | 1 |
| London Stock Exchange | 02.12.2022 | 17:35 | 177,56 USD | 0,01 | 3 |
| Hanover | 02.12.2022 | 11:45 | 170,02 EUR | 0,00 | 2 |
| Hamburg | 02.12.2022 | 08:02 | 169,36 EUR | 0,00 | 1 |
| Frankfurt | 02.12.2022 | 17:24 | 169,16 EUR | 0,03 | 7 |
| Duesseldorf | 02.12.2022 | 21:01 | 169,44 EUR | 0,00 | 12 |
| Berlin | 02.12.2022 | 08:08 | 169,48 EUR | 0,00 | 1 |
| 02.12.2022 22:26:25 | |
|---|---|
| Cena | |
| 169,84 EUR | |
| Změna | 0,00% (0,00) |
Základní údaje
| ISIN | US4781601046 |
| Symbol | JNJ |
| Burza | Tradegate |
| Měna | EUR |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 444.265 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | 169,50 EUR (88) |
| Prodej (částka) | 170,02 EUR (88) |
| Otevírací cena | 169,76 EUR |
| Max | 170,66 EUR |
| Min | 168,72 EUR |
| Závěrečná cena (předchozí den) | 169,84 EUR |
| Cena vážená obchodovaným objemem | 169,64646 EUR |
| Objem (kusy) | 4.706 |
| Obchodovaný objem | 798.356,26 |
| Počet obchodů | 142 |
| Poslední zobchodovaný počet | - |
Výkonnost a riziko
| 6m | 1r | 3r | |
| Výkonn. (%) | +2,79% | +21,81% | +36,61% |
| Výkonn. (abs.) | +4,60 | +30,34 | +45,40 |
| Beta | 0,34 | 0,29 | 0,54 |
| Volatilita | 18,06 | 19,86 | 22,49 |
Stupnice: ABS REL
Nástroj/produkt
Přidat benchmark:
Minulá výkonnost nezaručuje výkonnost budoucí.Zdroj: FactSet
Ceny
| Ø cena 5 dní| Ø objem 5 dní (ks.) | 170,46 EUR (5.861) |
| Ø cena 30 dní| Ø objem 30 dní (ks.) | 171,16 EUR (6.925) |
| Ø cena 100 dní| Ø objem 100 dní (ks.) | 168,26 EUR (6.695) |
| Ø cena 250 dní| Ø objem 250 dní (ks.) | 163,18 EUR (7.345) |
| YTD Max| datum | 178,20 EUR (12.07.2022) |
| YTD Min | datum | 131,50 EUR (21.02.2022) |
| 52týdenní max. | datum | 178,20 EUR (12.07.2022) |
| 52týdenní min. | datum | 131,50 EUR (21.02.2022) |
Logo společnosti
Kontakty
| JOHNSON & JOHNSON |
| - - |
| One Johnson & Johnson Plaza - 08933 New Brunswick |
| Telefon:1-732-524-0400 |
| Fax:- |
| E-mail:- |
PDF ke stažení
| Report společnosti: JOHNSON & JOHNSON | |
Profil společnosti
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ. |
Členové představenstva
| Alex Gorsky | Chairman of Board of Directors |
| A. Washington | Member of Board of Directors |
| Jennifer Doudna | Member of Board of Directors |
| Mark McClellan | Member of Board of Directors |
| Mary Beckerle | Member of Board of Directors |
| Nadja West | Member of Board of Directors |
| Anne Mulcahy | Member of Board of Directors |
| D. Davis | Member of Board of Directors |
| Darius Adamczyk | Member of Board of Directors |
| Hubert Joly | Member of Board of Directors |
| Ian Davis | Member of Board of Directors |
| Marillyn Hewson | Member of Board of Directors |
| Mark Weinberger | Member of Board of Directors |
| Joaquin Duato | Chairman of Managing Board |
| Mathai Mammen | Member of Executive Committee |
| Peter M. Fasolo | Member of Executive Committee |
| William N. Hait | Member of Executive Committee |
| Ashley McEvoy | Member of Executive Committee |
| James Swanson | Member of Executive Committee |
| Jennifer Taubert | Member of Executive Committee |
| Joseph Wolk | Member of Executive Committee |
| Kathryn E. Wengel | Member of Executive Committee |
| Michael H. Ullmann | Member of Executive Committee |
| Thibaut Mongon | Member of Executive Committee |
| Vanessa Broadhurst | Member of Executive Committee |